Biotechnology company (now rebranded as Genetix Biotherapeutics) developing genetic therapies for sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy
Biotechnology company (now rebranded as Genetix Biotherapeutics) developing genetic therapies for sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.